Johns Hopkins University School of Medicine
Timonium, MD, United States
Michelle Petri is a Professor of Medicine in the Division of Rheumatology and Director of the Lupus Center at the Johns Hopkins University School of Medicine and Johns Hopkins Hospital in Baltimore, Maryland. She earned her medical degree from Harvard Medical School in Boston, Massachusetts, completed her internship and residency in Internal medicine at Massachusetts General Hospital, and completed her Postdoctoral Fellowship in Allergy, Immunology, and Rheumatology at the University of California, San Francisco. She subsequently earned her master’s in Public Health and Epidemiology from johns Hopkins University Bloomberg School of Public Health.
Professor Petri’s research focuses on several aspects of systemic lupus erythematosus (SLE), including atherosclerosis, antiphospholipid syndrome (APS), lupus nephritis, and pregnancy. The Hopkins Lupus Cohort, started by Professor Petri in 1987, is a longitudinal study of the incidence and pathogenesis of thrombotic events and coronary artery disease in SLE. The Hopkins Lupus Pregnancy Center, of which Professor Petri is a Co-Director, has a database of over 400 pregnant patients, providing information on lupus activity, antiphospholipid tests, and pregnancy outcomes. As part of the Systemic Lupus International Collaborating Clinics, Dr. Petri participates in studies of atherosclerosis, malignancy, and neuropsychiatric lupus.
Updates in Systemic Lupus Erythematosus
Thursday, November 14, 2024
4:10 PM – 4:30 PM Eastern Time
Disclosure(s): Amgen: Advisor or Review Panel Member (Terminated, April 30, 2023); AnaptysBio: Advisor or Review Panel Member (Terminated, January 31, 2023); Annexon Bio: Advisor or Review Panel Member (Ongoing); Argenx: Advisor or Review Panel Member (Ongoing); Arhros-Focus Med/Ed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boxer Capital: Consultant (Ongoing); Cabaletto Bio: Consultant (Ongoing); Caribou Biosciences: Consultant (Ongoing); CTI Clinical Trial and Consulting Services: Advisor or Review Panel Member (Ongoing); CVS Health: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Terminated, December 30, 2023); Emergent Biosolutions: Advisor or Review Panel Member (Ongoing); Escient Pharmaceuticals: Advisor or Review Panel Member (Ongoing); Exagen: Grant/Research Support (Ongoing); Exo Therapeutics: Consultant (Ongoing); Gentibio: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Consultant (Ongoing); iCell Gene Therapeutics: Consultant (Ongoing); Idorsia Pharmaceuticals: Consultant (Terminated, July 31, 2022); IQVIA: Advisor or Review Panel Member (Ongoing); Janssen: Grant/Research Support (Ongoing); Kira Pharmaceuticals: Consultant (Terminated, March 31, 2023); MedShr: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, March 31, 2022); Merck/EMD Serono: Advisor or Review Panel Member (Ongoing); Nexstone Immunology: Consultant (Ongoing); Nimbus Lakshmi: Consultant (Ongoing); Proviant: Consultant (Ongoing); Regeneron Pharmaceuticals: Consultant (Ongoing); Sanofi: Consultant (Terminated, September 30, 2022); Seismic Therapeutic: Consultant (Ongoing); Sinomab Biosciences: Consultant (Ongoing); Takeda: Advisor or Review Panel Member (Ongoing); Tenet Medicines Inc: Consultant (Ongoing); TG Therapeutics: Advisor or Review Panel Member (Ongoing); UCB: Consultant (Terminated, January 31, 2022); Zydus: Consultant (Ongoing)
Updates in Systemic Lupus Erythematosus
Thursday, November 14, 2024
4:30 PM – 4:50 PM Eastern Time
Disclosure(s): Amgen: Advisor or Review Panel Member (Terminated, April 30, 2023); AnaptysBio: Advisor or Review Panel Member (Terminated, January 31, 2023); Annexon Bio: Advisor or Review Panel Member (Ongoing); Argenx: Advisor or Review Panel Member (Ongoing); Arhros-Focus Med/Ed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boxer Capital: Consultant (Ongoing); Cabaletto Bio: Consultant (Ongoing); Caribou Biosciences: Consultant (Ongoing); CTI Clinical Trial and Consulting Services: Advisor or Review Panel Member (Ongoing); CVS Health: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Terminated, December 30, 2023); Emergent Biosolutions: Advisor or Review Panel Member (Ongoing); Escient Pharmaceuticals: Advisor or Review Panel Member (Ongoing); Exagen: Grant/Research Support (Ongoing); Exo Therapeutics: Consultant (Ongoing); Gentibio: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Consultant (Ongoing); iCell Gene Therapeutics: Consultant (Ongoing); Idorsia Pharmaceuticals: Consultant (Terminated, July 31, 2022); IQVIA: Advisor or Review Panel Member (Ongoing); Janssen: Grant/Research Support (Ongoing); Kira Pharmaceuticals: Consultant (Terminated, March 31, 2023); MedShr: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, March 31, 2022); Merck/EMD Serono: Advisor or Review Panel Member (Ongoing); Nexstone Immunology: Consultant (Ongoing); Nimbus Lakshmi: Consultant (Ongoing); Proviant: Consultant (Ongoing); Regeneron Pharmaceuticals: Consultant (Ongoing); Sanofi: Consultant (Terminated, September 30, 2022); Seismic Therapeutic: Consultant (Ongoing); Sinomab Biosciences: Consultant (Ongoing); Takeda: Advisor or Review Panel Member (Ongoing); Tenet Medicines Inc: Consultant (Ongoing); TG Therapeutics: Advisor or Review Panel Member (Ongoing); UCB: Consultant (Terminated, January 31, 2022); Zydus: Consultant (Ongoing)
Updates in Systemic Lupus Erythematosus
Thursday, November 14, 2024
4:50 PM – 5:10 PM Eastern Time
Disclosure(s): Amgen: Advisor or Review Panel Member (Terminated, April 30, 2023); AnaptysBio: Advisor or Review Panel Member (Terminated, January 31, 2023); Annexon Bio: Advisor or Review Panel Member (Ongoing); Argenx: Advisor or Review Panel Member (Ongoing); Arhros-Focus Med/Ed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boxer Capital: Consultant (Ongoing); Cabaletto Bio: Consultant (Ongoing); Caribou Biosciences: Consultant (Ongoing); CTI Clinical Trial and Consulting Services: Advisor or Review Panel Member (Ongoing); CVS Health: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Terminated, December 30, 2023); Emergent Biosolutions: Advisor or Review Panel Member (Ongoing); Escient Pharmaceuticals: Advisor or Review Panel Member (Ongoing); Exagen: Grant/Research Support (Ongoing); Exo Therapeutics: Consultant (Ongoing); Gentibio: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Consultant (Ongoing); iCell Gene Therapeutics: Consultant (Ongoing); Idorsia Pharmaceuticals: Consultant (Terminated, July 31, 2022); IQVIA: Advisor or Review Panel Member (Ongoing); Janssen: Grant/Research Support (Ongoing); Kira Pharmaceuticals: Consultant (Terminated, March 31, 2023); MedShr: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, March 31, 2022); Merck/EMD Serono: Advisor or Review Panel Member (Ongoing); Nexstone Immunology: Consultant (Ongoing); Nimbus Lakshmi: Consultant (Ongoing); Proviant: Consultant (Ongoing); Regeneron Pharmaceuticals: Consultant (Ongoing); Sanofi: Consultant (Terminated, September 30, 2022); Seismic Therapeutic: Consultant (Ongoing); Sinomab Biosciences: Consultant (Ongoing); Takeda: Advisor or Review Panel Member (Ongoing); Tenet Medicines Inc: Consultant (Ongoing); TG Therapeutics: Advisor or Review Panel Member (Ongoing); UCB: Consultant (Terminated, January 31, 2022); Zydus: Consultant (Ongoing)
Updates in Systemic Lupus Erythematosus
Thursday, November 14, 2024
5:10 PM – 5:30 PM Eastern Time
Disclosure(s): Amgen: Advisor or Review Panel Member (Terminated, April 30, 2023); AnaptysBio: Advisor or Review Panel Member (Terminated, January 31, 2023); Annexon Bio: Advisor or Review Panel Member (Ongoing); Argenx: Advisor or Review Panel Member (Ongoing); Arhros-Focus Med/Ed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boxer Capital: Consultant (Ongoing); Cabaletto Bio: Consultant (Ongoing); Caribou Biosciences: Consultant (Ongoing); CTI Clinical Trial and Consulting Services: Advisor or Review Panel Member (Ongoing); CVS Health: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Terminated, December 30, 2023); Emergent Biosolutions: Advisor or Review Panel Member (Ongoing); Escient Pharmaceuticals: Advisor or Review Panel Member (Ongoing); Exagen: Grant/Research Support (Ongoing); Exo Therapeutics: Consultant (Ongoing); Gentibio: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Consultant (Ongoing); iCell Gene Therapeutics: Consultant (Ongoing); Idorsia Pharmaceuticals: Consultant (Terminated, July 31, 2022); IQVIA: Advisor or Review Panel Member (Ongoing); Janssen: Grant/Research Support (Ongoing); Kira Pharmaceuticals: Consultant (Terminated, March 31, 2023); MedShr: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, March 31, 2022); Merck/EMD Serono: Advisor or Review Panel Member (Ongoing); Nexstone Immunology: Consultant (Ongoing); Nimbus Lakshmi: Consultant (Ongoing); Proviant: Consultant (Ongoing); Regeneron Pharmaceuticals: Consultant (Ongoing); Sanofi: Consultant (Terminated, September 30, 2022); Seismic Therapeutic: Consultant (Ongoing); Sinomab Biosciences: Consultant (Ongoing); Takeda: Advisor or Review Panel Member (Ongoing); Tenet Medicines Inc: Consultant (Ongoing); TG Therapeutics: Advisor or Review Panel Member (Ongoing); UCB: Consultant (Terminated, January 31, 2022); Zydus: Consultant (Ongoing)
Glucosteroid Stewardship: A Reality in SLE
Sunday, November 17, 2024
10:50 AM – 11:10 AM Eastern Time
Disclosure(s): Amgen: Advisor or Review Panel Member (Terminated, April 30, 2023); AnaptysBio: Advisor or Review Panel Member (Terminated, January 31, 2023); Annexon Bio: Advisor or Review Panel Member (Ongoing); Argenx: Advisor or Review Panel Member (Ongoing); Arhros-Focus Med/Ed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boxer Capital: Consultant (Ongoing); Cabaletto Bio: Consultant (Ongoing); Caribou Biosciences: Consultant (Ongoing); CTI Clinical Trial and Consulting Services: Advisor or Review Panel Member (Ongoing); CVS Health: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Terminated, December 30, 2023); Emergent Biosolutions: Advisor or Review Panel Member (Ongoing); Escient Pharmaceuticals: Advisor or Review Panel Member (Ongoing); Exagen: Grant/Research Support (Ongoing); Exo Therapeutics: Consultant (Ongoing); Gentibio: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Consultant (Ongoing); iCell Gene Therapeutics: Consultant (Ongoing); Idorsia Pharmaceuticals: Consultant (Terminated, July 31, 2022); IQVIA: Advisor or Review Panel Member (Ongoing); Janssen: Grant/Research Support (Ongoing); Kira Pharmaceuticals: Consultant (Terminated, March 31, 2023); MedShr: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, March 31, 2022); Merck/EMD Serono: Advisor or Review Panel Member (Ongoing); Nexstone Immunology: Consultant (Ongoing); Nimbus Lakshmi: Consultant (Ongoing); Proviant: Consultant (Ongoing); Regeneron Pharmaceuticals: Consultant (Ongoing); Sanofi: Consultant (Terminated, September 30, 2022); Seismic Therapeutic: Consultant (Ongoing); Sinomab Biosciences: Consultant (Ongoing); Takeda: Advisor or Review Panel Member (Ongoing); Tenet Medicines Inc: Consultant (Ongoing); TG Therapeutics: Advisor or Review Panel Member (Ongoing); UCB: Consultant (Terminated, January 31, 2022); Zydus: Consultant (Ongoing)
Defining a path to remission in Systemic Lupus Erythematosus (SLE)
Monday, November 18, 2024
5:45 PM – 7:45 PM Eastern Time
No financial relationships with ineligible companies to disclose